GLP-1 Insurance Coverage · Updated July 2026
GLP-1 Insurance Coverage Guide: What Your Plan Covers in 2026
By The RX Index Research Team ·
Affiliate disclosure: Some links on this page are affiliate links. If you use them, The RX Index may earn a commission at no extra cost to you. Affiliate compensation does not change the factual coverage information on this page. Sponsored links are labeled.
This guide is educational and is not medical or legal advice. Coverage depends on your current plan documents, and a licensed clinician decides what treatment is right for you.
Here's the honest bottom line, up front: whether your plan pays comes down to six things -- your exact plan, the exact drug, the form it comes in, why it's prescribed, your plan's current rules, and the date. Medicare now covers certain weight-loss GLP-1s for $50 a month for people who qualify (through December 31, 2027). Medicaid depends on your state. No insurance? Manufacturer cash programs start as low as $149 a month for some doses.
A rejection usually turns on one phrase -- “prior authorization required” or “benefit excluded.” The first is often a paperwork problem you can fix. The second can mean the benefit isn't there at all. Tell those two apart, and you stop burning weeks chasing the wrong fix.
Start here: what just happened to you?
Find your situation and get your first move.
| What happened | What it might mean | Your first move |
|---|---|---|
| You're checking before you get a prescription | Coverage is still unknown | Look up the exact drug and form on your plan's drug list |
| Pharmacy says “prior authorization required” | The benefit may exist -- your plan wants proof first | Get the exact PA rules in writing |
| Plan says “not covered” or “excluded” | The benefit itself may be missing | Get the exclusion in writing before you re-file anything |
| You're on Medicare and want it for weight loss | You may belong in the new Medicare Bridge, not standard Part D | Check Bridge eligibility (jump to the Medicare section) |
| Your coverage just stopped | A plan or drug-list change -- not always a dead end | Ask for the effective date and a transition refill |
Not sure which treatment path fits you? The RX Index's Find My GLP-1 Path tool matches you to providers based on your state, insurance situation, medication preference, and budget.
Best for you / not for you
This guide IS for you if:
- You have insurance and want to know if your GLP-1 is covered
- You just got a denial, a “PA required,” a scary price, or a coverage-change letter
- Your coverage recently stopped and you're worried about running out
This guide is NOT for you if:
- You want a yes/no from your insurance card alone -- that's not how it works
- You need a legal ruling on your plan rights (contact your state insurance dept. or DOL's EBSA)
- You're comparing compounded cash-pay providers instead of checking insurance
What we actually verified for this guide (July 17, 2026)
- Medicare's GLP-1 Bridge drug list, eligibility, and cost -- from Medicare.gov and CMS
- Manufacturer cash prices -- from LillyDirect and NovoCare directly
- The FDA's February 2026 statement on compounded GLP-1 marketing -- from FDA.gov
- Employer coverage numbers -- from the KFF 2025 Employer Health Benefits Survey
- Appeal deadlines and the current external-review pause -- from HealthCare.gov
- Federal-plan rules -- from OPM, TRICARE, and the VA
- Ro's coverage checker and membership price -- from Ro
What we could not verify for you personally: whether your exact plan will approve your prescription, your medical eligibility, or your final pharmacy price.
Does Insurance Cover GLP-1 Medications in 2026?
Sometimes. Coverage depends on the exact medication, the form it comes in, the FDA-approved reason it's prescribed, your plan's current drug list, your type of insurance, and the date. A GLP-1 covered for diabetes may not be covered for weight loss -- even for the same person, on the same plan.
Insurance does not cover “GLP-1s” as a group. It covers one specific drug, for one specific reason, under one specific plan's rules, for the current year. Miss any of those and the answer flips. Six facts decide it:
- Your exact plan -- not just the carrier, but your plan. Employers and individuals buy very different versions.
- The exact drug -- Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda, or Foundayo.
- The form -- injection pen, KwikPen, vial, or tablet. Plans and programs treat these differently.
- The reason it's prescribed -- weight loss, type 2 diabetes, heart-risk, or sleep apnea.
- Your plan's current drug list (formulary) and rules -- a formulary is the list of drugs your plan covers, plus the strings attached.
- The date -- plans change coverage every year, and sometimes mid-year.
The single most useful skill on this page
Tell apart two things that look the same but need opposite responses:
- Prior authorization (PA) = your plan requires a review before it will pay. The benefit may exist, but approval and your final cost are not settled yet. Often fixable.
- A benefit exclusion = your plan does not cover this category at all. Re-sending the same PA a hundred times will not help. You need a different game plan.
Which GLP-1 Insurance Coverage Lane Are You In?
GLP-1 coverage works differently across eleven “lanes.” What controls your answer changes by lane, so find yours first. A carrier name does not tell you your lane; your plan documents do.
| Coverage lane | What actually controls your answer | Weight-loss path | Common roadblock | First thing to do |
|---|---|---|---|---|
| Self-funded job plan (employer pays claims itself) | Your employer's plan design + the PBM's rules | Only if your employer chose to include it | A flat employer exclusion, or strict PA/step rules | Get the Summary Plan Description + the written weight-loss drug rule |
| Fully insured job plan (employer buys from a carrier) | Your exact certificate + formulary + state rules | Depends on the plan and drug | Assuming the carrier's general policy is your policy | Ask for your plan ID, benefit certificate, and formulary |
| ACA Marketplace plan | Your enrolled plan's formulary and benefits | Plan-specific | Reading a generic carrier list, not your plan's | Check the insurer site, your Summary of Benefits, and call |
| Standard Medicare Part D | Your Part D plan + the FDA-approved reason | Weight-loss-only usually goes to the Bridge instead | Sending a diabetes case into the Bridge, or vice versa | Confirm the reason before choosing the path |
| Medicare GLP-1 Bridge | CMS rules (July 1, 2026 -- Dec 31, 2027) | Yes, if you meet CMS criteria | Wrong plan type, unmet BMI/condition rules, wrong product | Confirm Part D plan type + BMI/condition + product |
| Medicaid fee-for-service | Your state's drug list and rules | 11 states cover adult obesity (as of July 10, 2026) | Using an old state count, or wrong drug/form | Open your state's current drug list + PA bulletin |
| Medicaid managed care (MCO) | State policy plus your MCO's version | May differ from the state's own list | Only checking the state page, not your MCO | Find your MCO's name, then its formulary |
| FEHB / PSHB (federal employees) | OPM rules + your specific plan | Every plan must cover ≥1 GLP-1 weight-loss drug | Thinking the rule guarantees your preferred brand | Compare the plan brochure, formulary, and PA rules |
| TRICARE (military) | Your TRICARE plan type + PA | Eligible plans cover it with PA; For Life does not | Wrong plan category or non-network prescriber | Check the TRICARE formulary + your plan category |
| VA health care | VA formulary + your VA care team | Coordinated through VA weight-management care | Treating one clinic's process as a national rule | Contact your VA care team or MOVE! program |
| CHAMPVA | CHAMPVA's published rules | Not covered for weight loss alone | Assuming it follows TRICARE or commercial rules | Match the drug to one of CHAMPVA's approved reasons |
Sources: Medicare Bridge (Medicare.gov / CMS, July 2026); Medicaid count (The RX Index Medicaid tracker, July 10, 2026); FEHB (OPM, 2026); TRICARE (TRICARE.mil / Defense Health Agency, 2025--2026); CHAMPVA (VA.gov). Roadblock and first-move columns are our editorial read of those rules.
How Do I Check If My Plan Covers a GLP-1?
Search your plan's current drug list for the exact brand and form, then confirm it's covered for your reason and find out which rules apply. Save the written answer -- a quick phone “yes” is not a guarantee of payment.
- 1.Get your full plan name and plan ID. Off your card. “Aetna” is not enough -- you need the specific plan.
- 2.Search the drug list on your plan's pharmacy site for the exact drug and form (Wegovy pen ≠ Wegovy tablet ≠ Zepbound KwikPen).
- 3.Look for the strings. Is there a “PA,” “ST” (step therapy), or “QL” (quantity limit) code? Is weight-loss coverage excluded entirely?
- 4.Call member services and ask for the written policy. Get a reference number.
- 5.Have the pharmacy run it once you have a real prescription -- the processed claim is the most concrete answer you'll get.
Copy this call script
- --“Is [exact drug and form] on my specific plan's drug list when it's prescribed for [reason]?”
- --“Does my plan include weight-loss (anti-obesity) medication as a benefit, or is that category excluded?”
- --“What are the exact prior authorization, step therapy, quantity, and renewal rules?”
- --“Can you email or mail me the current policy or criteria?”
- --“What's the effective date of this rule?”
- --“If I'm denied, what are my appeal and exception rights -- and the deadlines?”
- --“Please give me a reference number for this call.”
Save all of it: the drug-list date, the policy, the rep's name or ID, the reference number, and any pharmacy rejection message. That paper is your ammunition if you have to appeal later.
Sponsored
Get a free written report of which GLP-1s your plan may cover
Ro's insurance team contacts your plan and emails you a personalized report explaining coverage for each medication, whether prior authorization is required, and any available copay or cost estimates. New Ro accounts also get a $50 credit. The checker does not submit a treatment request, write a prescription, replace a medical visit, or decide your final claim -- but it can save you the phone marathon. Verified on Ro's site, July 2026. Affiliate link.
Get My Free Coverage Report at Ro (sponsored affiliate link, opens in a new tab)One honest caveat: this report is informational. Medicare Bridge and Medicaid readers should use the official program resources further down this page before relying on any commercial checker.
Denial Decoder: What “Prior Authorization,” “Step Therapy,” and “Excluded” Mean
These words describe different roadblocks, and each needs a different response. Prior authorization usually means the benefit exists but your plan wants proof. A category exclusion may mean the benefit is not there at all -- so re-sending the same request will not fix it.
| What your denial says | What it usually means | Fixable? | Your next move | Don't do this |
|---|---|---|---|---|
| “Prior authorization required” | Benefit may exist; plan wants clinical proof | Often | Get the exact criteria; have your doctor answer each one | Send a generic letter before reading the rules |
| “Step therapy required” | Try a covered alternative first (or get an exception) | Often | Document what you've tried, or why it's unsafe/won't work | Just argue your drug is “better” |
| “Quantity limit exceeded” | Dose, amount, or refill timing breaks a plan rule | Sometimes | Check if it's titration, days' supply, or timing | Assume the drug itself is banned |
| “Non-formulary” | Plan does not list this exact product as covered | Sometimes | Ask which drugs are covered, and about a formulary exception | Confuse this with a full category exclusion |
| “Not medically necessary” | The record did not meet the plan's clinical bar | Often | Find the missing criterion; answer it with records | Re-send the identical packet |
| “Missing information” | A required number, form, or record is missing | Usually | Fix the gap and resubmit fast | Launch a full appeal before fixing an obvious omission |
| “Benefit / category exclusion” | Plan may not cover weight-loss drugs at all | Hardest | Get it in writing, check for error, then exception/appeal/employer/enrollment | Repeat the same PA forever |
| “Not FDA-approved use / off-label” | The reason submitted does not match the drug's approved use | Often hard | Ask your clinician about a covered FDA-approved option | Never change a diagnosis to fit |
| “Continuation criteria not met” | You were approved before; renewal proof is short | Maybe | Pull your starting numbers, results, and the renewal deadline | Treat it like a brand-new request |
| “Coverage ended / formulary changed” | A plan or drug-list change removed or limited it | Depends | Get the date + reason; ask about transition fill, exception, appeal | Assume a new PA alone reverses a plan change |
The one document that matters most: the full written denial or exclusion -- not the short message on the pharmacy screen. It names the exact reason and rule, and everything else you do flows from it.
How Do I Get Prior Authorization for a GLP-1?
Start by getting your plan's written PA criteria for the exact drug, form, and reason -- then map every point to accurate records. A generic “this is medically necessary” letter may not address the plan's actual criteria; a stronger request answers each applicable criterion with documentation.
Who does what. Usually your prescriber and their PA staff fill out the form, the pharmacy or PBM routes it, and the plan reviews it. You're the records coordinator -- you make sure your doctor has what they need. You do not choose diagnoses or codes.
What the plan may ask for (every plan differs):
- Your exact diagnosis and the reason for treatment
- Current and starting measurements when they matter (like BMI)
- Related conditions (heart disease, sleep apnea, prediabetes)
- What you've tried before
- Any required lifestyle-program or counseling records
- Reasons a preferred drug is unsafe or won't work for you
- Your clinician's rationale, and the exact product and form
- For a renewal: proof of how you've responded
PA worksheet -- fill in with your prescriber:
| Plan criterion (from the policy) | Where it's shown in my record |
|---|---|
| e.g., BMI ≥30, or ≥27 with a condition | chart note, date |
| prior treatment tried | record, date |
PA mistakes to skip
Filing before you read the criteria · asking for the wrong form of the drug · leaving out a required prior treatment · using vague “medically necessary” language · copying a template · missing the renewal date · re-sending unchanged paperwork.
Save your starting line. Baseline numbers, approval dates, results, side effects, follow-up notes, and your renewal deadline. A common reason renewals get denied: the required baseline or continuation records are missing.
What Should I Do If Insurance Denies My GLP-1?
First, figure out the category of your denial -- a missing-document rejection is not the same as a medical-necessity denial or a benefit exclusion, and each has a different fix. For most private plans you generally have 180 days to file an internal appeal, but the deadline and steps in your written notice are what count. (Source: HealthCare.gov.)
The 10-minute denial triage
- Read the whole denial. Twice.
- Highlight the reason and the rule it cites.
- Write down the date you received it (your clock starts here).
- Decide which it is: correction, resubmission, exception request, internal appeal, external review, or a plan-design problem.
- Ask the plan for the full criteria or plan language.
- Tell your prescriber the exact missing piece.
Correct-and-resubmit, or appeal?
Correct and resubmit when:
- A form field was wrong
- A record was left out
- It went to the wrong place
- You have new information
Often the fastest fix.
Appeal when the plan:
- Applied its own rule wrong
- Disputed your clinician's judgment
- Ignored evidence
- Denied an exception you believe you qualify for
Build your appeal packet
- The denial notice
- The plan policy it cites
- Your original PA
- New or corrected records
- A prescriber letter that answers the denial point by point
- Records of prior treatments
- The FDA label, only where it's directly relevant
- A timeline of your calls and submissions
- A representative form, if someone's filing for you
The deadlines that matter (verified -- but your notice wins)
- Internal appeal: generally within 180 days of the denial notice. (HealthCare.gov)
- External review (an independent outside decision): generally request it within 4 months of your final internal denial, when eligible. The reviewer's decision is binding on your insurer. Standard reviews: 45 days; urgent: 72 hours. (HealthCare.gov)
Time-sensitive note (verified July 2026)
The federal government's external-review process (FERP) is temporarily paused as of July 1, 2026 for affected plans in Alabama, Florida, Georgia, Texas, Wisconsin, and a U.S. territory other than Puerto Rico. HHS says it's working on a fix and may extend deadlines. Follow your final denial notice for exactly where and when to file. (HealthCare.gov)
Your printable denial checklist
□The full written denial notice (saved)
□The exact reason and rule it cites (highlighted)
□Date received: ________ → Appeal deadline: ________
□Which type: correction · resubmission · exception · internal appeal · external review
□Plan's written criteria requested (call reference #: ________)
□Prescriber notified of the exact missing piece
□Prior-treatment records gathered
□Prescriber letter that answers the denial point by point
□Insurer call log (date, name/ID, what they said, reference #)
What If My Employer or Plan Drops My GLP-1?
A new rejection after months of coverage often means a formulary change, an expired authorization, a new renewal rule, or a real benefit cut -- not necessarily a permanent “no.” Get the effective date and reason in writing, ask about a transition refill and an exception, and talk to your prescriber before you change or stop anything.
Your first 24 hours
- Ask the pharmacy for the exact rejection message.
- Call the plan and pin down which it is: expired PA, formulary change, preferred-brand switch, new renewal criteria, or an employer benefit cut.
- Ask about a transition fill (30--90 days while you sort it out) and a continuity-of-care exception.
- Tell your prescriber what changed.
Losing coverage is frustrating -- but “my plan changed” and “I'm out of options” are not the same sentence. Possible next moves include a transition fill, an exception, an appeal, a covered alternative, or a cash-pay path. You have moves.
Can Insurance Cover a GLP-1 If I Don't Have Diabetes?
Yes. Coverage without diabetes is possible when the exact product has another FDA-approved use that applies to you and your plan covers that benefit. The product, form, diagnosis, formulary, and prior-authorization rules still control the decision.
Two different things people mix up:
- Meeting a drug's medical criteria (like a BMI threshold)
- Your plan actually including weight-loss medication as a benefit
You can meet the first and still be denied on the second. So don't read “I qualify medically” as “my plan will pay.” Beyond weight loss, some GLP-1s are FDA-approved for other reasons -- heart disease (Wegovy), sleep apnea (Zepbound) -- that can open a coverage door when weight-loss coverage is closed.
Which GLP-1 Medications and Forms Are Covered for Which Uses?
Insurance looks at a specific product, form, and reason -- not the GLP-1 class as one interchangeable benefit. A plan may cover one product for one FDA-approved use while denying another product or form, even when they're related.
| Drug (molecule) | FDA-approved use(s) | The reason most likely to get it covered |
|---|---|---|
| Ozempic (semaglutide) | Type 2 diabetes; cardiovascular-risk reduction with diabetes + heart disease | Type 2 diabetes (broad, consistent coverage) |
| Mounjaro (tirzepatide) | Type 2 diabetes | Type 2 diabetes |
| Wegovy (semaglutide, injection or tablet) | Chronic weight management; cardiovascular-risk reduction in adults with heart disease + overweight/obesity; noncirrhotic MASH with liver fibrosis | Weight loss (if your plan covers it), OR the heart-risk or MASH reason |
| Zepbound (tirzepatide, injection) | Chronic weight management; moderate-to-severe obstructive sleep apnea in adults with obesity | Weight loss (if covered), OR the sleep-apnea reason |
| Saxenda (liraglutide) | Chronic weight management | Weight loss (if covered) |
| Foundayo (orforglipron, oral) | Chronic weight management (approved April 2026) | Weight loss (if covered); commercial coverage is still thin |
Each FDA-approved use should be confirmed against the drug's current FDA label before you rely on it -- labels change. Sources: FDA labels and approvals.
If you're denied for weight loss but you also have established heart disease (Wegovy) or moderate-to-severe sleep apnea (Zepbound), ask your prescriber whether submitting under that FDA-approved reason fits your real diagnosis.
Does Medicare Cover GLP-1 Medications in 2026?
Yes -- through two separate paths. Standard Part D may cover GLP-1s prescribed for Part-D-coverable FDA-approved reasons (like type 2 diabetes), subject to your plan's formulary and rules. And the new Medicare GLP-1 Bridge covers certain weight-loss GLP-1s for eligible Part D members from July 1, 2026 through December 31, 2027, for a flat $50 a month. (Source: Medicare.gov / CMS.)
Standard Part D vs. the Medicare GLP-1 Bridge
| Question | Standard Part D | Medicare GLP-1 Bridge |
|---|---|---|
| Main purpose | Covered FDA-approved reasons (diabetes, etc.) | Weight loss under CMS criteria |
| Who runs it | Your Part D plan | A separate CMS program |
| Drug list | Your plan's | A fixed CMS list |
| Your cost | Plan-specific | $50/month |
| Appeal | Normal Part D appeals | No Bridge appeal -- but you can resubmit corrected info |
| Ends | Ongoing | Dec 31, 2027 |
Who qualifies for the Bridge
You must be 18+, have Medicare Part D, and be using the drug for weight management -- your prescriber must attest that it's being used along with ongoing lifestyle changes (structured nutrition and physical activity). Then you must meet one of these (verified on Medicare.gov / CMS):
- BMI 35 or higher, or
- BMI 30--34.9 plus one of: heart failure with preserved ejection fraction, uncontrolled high blood pressure, chronic kidney disease (stage 3a or higher), prediabetes, a past heart attack or stroke, or symptomatic peripheral artery disease
- BMI 27--29.9 plus one of: prediabetes, a past heart attack or stroke, or symptomatic peripheral artery disease
You're not eligible if you already get GLP-1s covered by your Part D plan, or if you have type 2 diabetes, moderate-to-severe obstructive sleep apnea, or noncirrhotic MASH -- but your Part D plan may cover a GLP-1 for those reasons instead.
Which drugs and forms the Bridge covers
- Foundayo (tablet)
- Wegovy (injection or tablet)
- Zepbound KwikPen only -- not the single-dose vial or single-dose pen
And a detail people miss: pen needles are not covered by the Bridge -- you buy those separately. (Medicare.gov)
The catch nobody explains
Your $50 copay runs through a separate program, so it does not count toward your Part D deductible or yearly out-of-pocket max. It won't show up on your Explanation of Benefits. It cannot be lowered by Extra Help or spread out with the Medicare Prescription Payment Plan. (Medicare.gov)
BALANCE will not launch in Medicare Part D in 2027 -- CMS extended the Medicare GLP-1 Bridge through December 31, 2027 instead. Once approved, your Bridge prior authorization stays valid through December 31, 2027 (including refills and dose changes) unless you switch GLP-1s. (Medicare.gov)
Does Medicaid Cover GLP-1 Medications for Weight Loss?
It depends entirely on your state. Coverage shrank during 2026: our Medicaid tracker fell from 13 listed programs earlier in the year to 11 as of July 10, 2026. Exact drugs, rules, and your managed-care plan's version can all differ from the state's headline policy.
Current snapshot (verified July 10, 2026):
- 11 states currently cover GLP-1s for adult obesity
- Utah ended coverage June 30, 2026
- Massachusetts ended coverage July 1, 2026
- Rhode Island moves to diabetes-only on October 1, 2026
Always confirm your own plan's current drug list before you count on coverage.
Fee-for-service vs. managed care
Two people in the same state can still get different answers. Many Medicaid enrollees get their benefits through a managed care organization (MCO) -- a private plan that runs your Medicaid coverage -- and the MCO's drug list can differ from the state's own. Identify: your state, whether you're fee-for-service or MCO, your MCO's name, your exact drug and form, and the current drug list and PA bulletin.
If your state does not cover adult obesity
- Confirm the “no” is specifically for adult obesity coverage (not a paperwork slip).
- Ask your clinician whether a different FDA-approved product is medically appropriate for a diagnosis you actually have.
- Get the written policy and your appeal rights.
- Review covered alternatives with your prescriber.
- Only then compare cash-pay treatment paths.
Does Employer or Marketplace Insurance Cover GLP-1s?
Your job or Marketplace plan is controlled by the exact plan, not the carrier. In the KFF 2025 Employer Health Benefits Survey, 19% of large firms (200+ workers) covered GLP-1s primarily for weight loss -- rising to 43% at the biggest firms (5,000+ workers). Even where it's covered, strings often apply.
What employers actually cover (KFF 2025)
| Firm size | Covered GLP-1s primarily for weight loss (2025) |
|---|---|
| 200--999 workers | 16% |
| 1,000--4,999 workers | 30% |
| 5,000+ workers | 43% |
| All firms with 200+ workers | 19% |
Among firms that do cover them, 34% require you to meet with a dietitian, case manager, or therapist, or join a lifestyle program, in order for the drug to be covered. Most large firms (57%) still do not cover these drugs for weight loss. (KFF 2025 Employer Health Benefits Survey)
Marketplace: check all four sources
- The insurer's website
- Your Summary of Benefits and Coverage
- A direct call to the insurer
- Your mailed plan materials
Do FEHB, TRICARE, VA, and CHAMPVA Cover GLP-1 Medications?
Check federal plans on their own -- do not assume they follow commercial rules. FEHB plans must offer at least one GLP-1 weight-loss drug; eligible TRICARE plans cover it with prior authorization (but For Life does not); VA access runs through VA care; and CHAMPVA does not cover GLP-1s for weight loss alone. (Sources: OPM, TRICARE, VA.)
| Program | Weight-loss path | The catch you cannot miss | First source to check |
|---|---|---|---|
| FEHB / PSHB | Every plan must offer ≥1 GLP-1 weight-loss drug (plus 2 oral options) | The rule does not guarantee your preferred brand or price | Plan brochure, formulary, PA rules |
| TRICARE | Eligible plans (Prime, Select, Young Adult, Reserve Select, Retired Reserve, CHCBP) cover Wegovy/Zepbound with PA + criteria | TRICARE For Life, direct-care-only, and NATO/PfP beneficiaries are excluded from the weight-loss benefit | TRICARE formulary + your plan type |
| VA | Through VA clinical + weight-management care | One clinic's process is not a national guarantee | Your VA care team or MOVE! program |
| CHAMPVA | Not covered for weight loss alone | Covered only for specific approved conditions (e.g., type 2 diabetes, sleep apnea) | VA CHAMPVA medication page |
FEHB: the “must offer at least one” rule is real, but it's not a promise your favorite brand is covered at a low price. For plan year 2027, OPM requires documented participation in intensive behavioral therapy before and while an anti-obesity medication is covered. TRICARE For Life: if you're on TFL, your weight-loss GLP-1 coverage ended in 2025 -- though diabetes GLP-1s stay covered.
How Much Does a GLP-1 Cost With Insurance?
“Covered” does not mean one price. What you actually pay depends on your deductible, the drug's tier, your copay or coinsurance, your pharmacy, quantity rules, and any savings program you qualify for. The same “covered” drug can cost $25 for one person and hundreds for another.
Ask for the price that matters: “What's my expected cost for this exact drug, dose, pharmacy, and fill date after the claim is processed?”
Manufacturer cash-pay prices (verified July 17, 2026)
| Program and payment type | Starting price (verify current) | Key thing to know |
|---|---|---|
| NovoCare -- Wegovy tablets | $149/mo (1.5 mg; and 4 mg through Aug 31, 2026, then $199) | Higher tablet doses cost more |
| NovoCare -- Wegovy pen | $199/mo first 2 fills for new patients (0.25 / 0.5 mg), then $349/mo; Wegovy HD 7.2 mg is $399/mo | Intro pricing is temporary |
| LillyDirect -- Zepbound (vial or KwikPen) | $299 (2.5 mg) / $399 (5 mg); $449 for 7.5--15 mg under the Self Pay Journey offer | Regular price is $499--$699 for higher doses; $449 offer requires a refill within 45 days; pen needles cost extra |
| LillyDirect -- Foundayo (oral) | $149 (0.8 mg) up to $349 (top doses) | A $299 offer applies to the top doses with a 45-day refill |
| With commercial insurance + manufacturer savings card | As little as $25/mo per fill | Your plan has to cover the drug first; savings cards are not available to Medicare/Medicaid/TRICARE/VA beneficiaries |
Sources: LillyDirect and NovoCare, verified July 17, 2026. Verify all prices before relying on them -- they move. Retail without a program is steep: Wegovy's list price is around $1,349/month.
What Are My Options If Insurance Won't Pay?
A “no” from insurance should trigger a sequence, not a random provider switch. Work it in this order:
- Fix errors -- a wrong field or missing record.
- Finish PA or step therapy if it's medically appropriate.
- Request a formulary or quantity exception.
- File an internal appeal.
- Ask for external review where it applies.
- Ask about a covered FDA-approved alternative -- your clinician decides.
- Check manufacturer cash programs (the table above).
- Consider telehealth insurance support.
- Consider a clearly separate compounded path -- only after you understand what it is.
Fair admission on telehealth
If your current doctor will prescribe the right FDA-approved drug and handle the prior authorization quickly, you may not need to pay for a separate telehealth membership at all. Telehealth earns its fee when its value is the coverage work -- verifying your benefits, handling PA paperwork, and coordinating with the insurer so you're not doing it alone on hold.
For commercially insured readers who want a free coverage report plus hands-on PA support, Ro does two concrete things well: a free personalized coverage report, and an insurance concierge (part of the Ro Body membership) that verifies benefits and handles prior-authorization paperwork.
| Claim | Status |
|---|---|
| Free coverage report; contacts your insurer | Provider-stated, confirmed on Ro's current page |
| Report explains coverage + any available cost estimates | Provider-stated, confirmed on Ro's current page |
| Checker does not submit treatment or write a prescription | Confirmed on Ro's current page |
| $50 new-account credit | Confirmed on Ro's current page |
| $39 first month / $149 monthly / as low as $74 with annual prepay | Confirmed on Ro's current pricing page |
| Final approval and final pharmacy price | Not guaranteed -- no provider can promise this |
Sponsored
See FDA-approved GLP-1 options with insurance support
Get started for $39. Ongoing membership is $149/month, or as low as $74/month with an annual plan paid upfront. Medication is billed separately. A licensed clinician decides whether treatment is appropriate, and insurance coverage is not guaranteed. Verified July 17, 2026.
See My Coverage Options at Ro (sponsored affiliate link, opens in a new tab)Ro is not free -- there is a membership fee on top of medication. Best for commercially insured readers. Medicare and Medicaid: use the official program resources on this page instead.
A clearly separate path: compounded GLP-1 medication
Compounded GLP-1 drugs are not FDA-approved. In February 2026, the FDA said it cannot verify the quality, safety, or effectiveness of these non-approved products, and that sellers cannot claim they're generic versions of, the same as, or made with the same active ingredient as FDA-approved drugs, or that they're “clinically proven.” (Source: FDA.gov.)
Compounded programs are commonly offered as cash-pay treatment paths -- verify any claimed insurance benefit directly with your plan.
How Did The RX Index Build and Verify This Guide?
We assembled this from authoritative government sources, FDA labels, official plan and program documents, current provider pages for provider-stated facts, and reputable survey data -- and put a verification date on facts that change. We label official rules, current commercial facts, and our own editorial judgments separately.
Source ranking: (1) the law or agency that made the rule, (2) the FDA label, (3) the official plan or program document, (4) the provider's own page for its own facts, (5) reputable surveys, (6) our editorial read of those facts.
What this is not: a guarantee your plan will pay, legal advice, medical advice, a diagnosis, or a substitute for your own plan documents.
Corrections and update log
| Date | What changed | Source rechecked |
|---|---|---|
| Confirmed Medicare Bridge runs through Dec 31, 2027; noted BALANCE will not launch in Part D in 2027 | Medicare.gov / CMS | |
| Updated Medicaid count to 11 states | The RX Index tracker | |
| Rebuilt cash-price table from LillyDirect and NovoCare | Manufacturer pages | |
| Confirmed the federal external-review (FERP) pause | HealthCare.gov |
Frequently Asked Questions
These answers cover the plan, denial, Medicare, Medicaid, pricing, and product questions most likely to send you back to search. Each one points to the controlling detail and your next move.
Does insurance cover GLP-1 medications without diabetes?▼
Which insurance companies cover Wegovy or Zepbound?▼
Why would insurance cover Ozempic but not Wegovy?▼
Does prior authorization mean my medication is covered?▼
Can I appeal if my plan excludes weight-loss drugs?▼
What happens when a prior authorization expires?▼
Does the Medicare Bridge cover every form of Zepbound?▼
Are the Zepbound KwikPen needles covered by the Medicare Bridge?▼
Which Medicaid programs cover GLP-1s for adult obesity?▼
Can I use a manufacturer savings card with Medicare or Medicaid?▼
Does insurance cover compounded GLP-1s?▼
How often should I recheck my coverage?▼
Still not sure which GLP-1 program is right for you?
Take our free Find My GLP-1 Path quiz -- a personalized match based on your state, insurance, medication preference, and budget.
Find My GLP-1 Path →Sources and Verification Record -- Last Rechecked July 17, 2026
- Medicare GLP-1 Bridge -- Medicare.gov, Weight loss drugs, and CMS Bridge provider guidance (drugs covered, eligibility, lifestyle attestation, plan types, cardiovascular routing, cost, needles, dates)
- FDA -- FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs (Feb 6, 2026)
- KFF -- 2025 Employer Health Benefits Survey (employer GLP-1 coverage rates)
- HealthCare.gov -- Internal appeals and External review (180-day / 4-month windows; external-review eligibility; FERP pause)
- OPM -- FEHB/PSHB anti-obesity medication requirement (2026 coverage; 2027 intensive behavioral therapy rule)
- TRICARE.mil / Defense Health Agency -- weight-loss medication coverage, eligible plans, and the TRICARE For Life change (Aug 31, 2025)
- VA.gov -- CHAMPVA covered medications
- LillyDirect (Zepbound, Foundayo) and NovoCare (Wegovy) -- current self-pay and savings-card pricing
- Ro -- GLP-1 Insurance Coverage Checker, insurance concierge, and Ro Body membership pricing
- The RX Index -- Medicaid coverage tracker (last verified July 10, 2026)
Related guides
Your situation changes the answer
Find My GLP-1 Path
The right GLP-1 provider isn't the same for everyone. It depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred route (injection or oral), and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a personalized provider match with source-verified pricing before you choose.
- What it asks: your state, insurance situation, medication preference, budget, and support needs
- What you get: a personalized shortlist of GLP-1 providers matched to your situation, with verified pricing and the right questions to ask
- Cost: free · about 2 minutes · no signup